News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX goes missing as new premiums lift health stocks; Bitcoin at US$68k
News
ASX Large Caps: AI craze sweeps ASX; Block Inc, Aussie Broadband up 17pc, Newmont dips 7pc
Health & Biotech
ASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemia
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ASX Health Stocks: US bound Telix plans dual listing on the NASDAQ
News
Market Highlights: Magnificent 7 all at sea in New York as iron ore trades higher
Health & Biotech
ASX Health Stocks: dorsaVi up 27pc on US deals, Starpharma reports positive outcome on Phase 2 trial
Experts
The Wulff: It’s time to meet the ASX Sectors of the Year
News
ASX Large Caps: Commodity stocks push ASX higher, Telstra down 2pc on expansion plan
News
ASX Large Caps: Rates sensitive stocks rally hard; Origin Energy slumps on rejected offer
News
ASX Large Caps: ASX slumps 1.5pc as gold stocks rally on safe-haven flight; jobless rate unexpectedly up
Health & Biotech
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
Health & Biotech
Global biotech sector set to boom but where are Aussie investors?
Explainers
ASX cancer stocks guide: Here’s everything you need to know
News
ASX Small Caps Lunch Wrap: Has America’s ultimate porch pirate been found this week?
Experts
MoneyTalks: How and where to spot multibaggers, and a couple of fundie’s recommendations
News